Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Letter by Govindarajan and Salgado regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial".
Govindarajan R, Salgado E. Govindarajan R, et al. Among authors: salgado e. Circulation. 2012 Jan 24;125(3):e290; author reply e293-4. doi: 10.1161/CIRCULATIONAHA.111.053710. Circulation. 2012. PMID: 22271856 No abstract available.
Dabigatran and thrombolysis: A therapeutic dilemma.
Govindarajan R, Salgado E. Govindarajan R, et al. Among authors: salgado e. Ann Neurol. 2012 Oct;72(4):625; author reply 625-6. doi: 10.1002/ana.23686. Ann Neurol. 2012. PMID: 23109156 No abstract available.
Is it too early to predict the failure of natalizumab in NMO?
Govindarajan R, Salgado E. Govindarajan R, et al. Among authors: salgado e. Arch Neurol. 2012 Aug;69(8):1085; author reply 1086. doi: 10.1001/archneurol.2012.1138. Arch Neurol. 2012. PMID: 22892674 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 35798542
278 results